000 | 00904 a2200241 4500 | ||
---|---|---|---|
005 | 20250517160538.0 | ||
264 | 0 | _c20181024 | |
008 | 201810s 0 0 eng d | ||
022 | _a1468-330X | ||
024 | 7 |
_a10.1136/jnnp-2017-315768 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKim, Su-Hyun | |
245 | 0 | 0 |
_aA step forward towards personalised immunosuppressive therapy in neuromyelitis optica spectrum disorder. _h[electronic resource] |
260 |
_bJournal of neurology, neurosurgery, and psychiatry _c08 2017 |
||
300 |
_a619 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aAquaporin 4 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aNeuromyelitis Optica |
700 | 1 | _aKim, Ho Jin | |
773 | 0 |
_tJournal of neurology, neurosurgery, and psychiatry _gvol. 88 _gno. 8 _gp. 619 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/jnnp-2017-315768 _zAvailable from publisher's website |
999 |
_c27270625 _d27270625 |